Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users

Pharmacogenomic testing is a method to prevent adverse drug reactions. Pharmacogenomics could be relevant to optimize statin treatment, by identifying patients at high risk for adverse drug reactions. We aim to investigate the clinical validity and utility of pre-emptive pharmacogenomics screening i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Marleen E., Rigter, Tessel, Fleur, Thom M. C., Souverein, Patrick C., Verschuren, W. M. Monique, Vijverberg, Susanne J., Swen, Jesse J., Rodenburg, Wendy, Cornel, Martina C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957000/
https://www.ncbi.nlm.nih.gov/pubmed/36833383
http://dx.doi.org/10.3390/genes14020456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957000/
https://www.ncbi.nlm.nih.gov/pubmed/36833383
http://dx.doi.org/10.3390/genes14020456

Ejemplares similares